Retraction: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
- PMID: 38843134
- PMCID: PMC11156375
- DOI: 10.1371/journal.pone.0305303
Retraction: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Retraction of
-
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.PLoS One. 2020 Sep 25;15(9):e0239799. doi: 10.1371/journal.pone.0239799. eCollection 2020. PLoS One. 2020. Retraction in: PLoS One. 2024 Jun 6;19(6):e0305303. doi: 10.1371/journal.pone.0305303. PMID: 32976513 Free PMC article. Retracted.
References
-
- Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, et al.. (2020) Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS ONE 15(9): e0239799. doi: 10.1371/journal.pone.0239799 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
